6533b7d9fe1ef96bd126cb97

RESEARCH PRODUCT

Long-Term Safety of Tiotropium/Olodaterol Respimat in Patients with Moderate-to-Very Severe COPD and Renal Impairment in the TONADO Studies

Roland BuhlUlrich BothnerS StieglitzL LoaizaEric DeromCraig LaforceMatthias Trampisch

subject

Pulmonary and Respiratory Medicinemedicine.medical_specialtyRespimatbusiness.industryInternal medicinemedicineTiotropium-olodaterolIn patientLong term safetySevere copdbusinesshttps://doi.org/10.1055/s-0037-1619340